Aligos Therapeutics, Inc.

Historical 13F Holders

Symbol
ALGS
CUSIP
01626L204
All holders as of
Q3 2026
Type
Equity
Class
COM NEW
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 01626L204 since 12/18/2024, largest first.

Filer % of Class Filed
Alyeska Investment Group, L.P. 13G/A
5.6% 11/16/2026
Event 9/30/2026
Blatt Lawrence 13D 5.6% 6/24/2026
Event 6/16/2026
Sio Capital Management, LLC 13G/A 5.5% 2/11/2026
Event 12/31/2025
Parkman Healthcare Partners LLC 13G
5.2% 11/13/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Armistice Capital, LLC 13G/A
4.99% 2/14/2025
Event 12/31/2024
Woodline Partners LP 13G/A 4.4% 5/15/2026
Event 3/31/2026
EcoR1 Capital, LLC 13G/A
3.9% 5/15/2025
Event 3/31/2025
Adage Capital Management, L.P. 13G/A
3.9% 8/12/2025
Event 6/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 36 2.53 M $14.3M
2026 Q2 31 2.29 M $13.2M
2026 Q1 34 2.78 M $20.6M
2025 Q4 40 2.81 M $26.2M
2025 Q3 34 2.65 M $26.0M
2025 Q2 38 2.71 M $19.5M
2025 Q1 37 3.30 M $27.1M
2024 Q4 34 1.62 M $64.5M
2024 Q3 28 1.69 M $14.7M